Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Search results

Found 15 matches for

The collective force of cancer research, outreach and care across the city of Oxford, translating discoveries into better care for cancer patients.

DNA link could unlock mystery of cancer patients ‘wasting away’

New research by Oxford researchers into sudden weight loss finds a possible cause of cachexia (sudden weight loss & muscle wasting) in cancer patients and Cockayne syndrome in children.

Toral Gathani awarded Professorship for work into ethnicity and breast cancer

Toral Gathani has been awarded a prestigious Hunterian Professorship (2022) by the Royal College of Surgeons of England. The award recognises her work on ethnicity and breast cancer.

Strong immune responses in myeloma patients after two doses of COVID vaccine

A study of 214 patients with myeloma finds that 93% of them produced T cells as well as antibodies to the SARS-CoV-2 spike protein after two doses of a COVID vaccine.

Advancing radiotherapy technology through clinical trials

Rob Stepney participated in a radiotherapy clinical trial in Oxford in 2021. He talks about his experience on the trial and accessing a state-of-the-art machine that uses real-time imaging to improve tumour targeting.

Haematology workshops enable significant patient involvement

The 'What Matters Most’ initiative was designed as a way of bringing people with Myelodyspastic Syndrome together to talk about their shared experience, and agree a list of priorities for research and service / resource development.

Artwork donated to Oxford ward for patients undergoing cancer clinical trials

A generous donation by artist Lida Sherafatmand has seen three prints installed into the Early Phase Clinical Trials Unit at the Churchill Hospital in Oxford.

Prioritising COVID-19 research questions for the cancer population

UK Coronavirus Cancer Monitoring Project (UKCCMP) lead Dr Lennard Lee talks to the NCRI about what clinician-patient collaboration and public involvement in research can do for cancer research and its outcomes

New Oxford technology assesses cancer patient vulnerability to COVID-19

New research from Prof Julia Hippisley-Cox has resulted in thousands of cancer patients being given prioritised access to the COVID-19 vaccine.

Bowel cancer patients going undiagnosed due to COVID distruption

A new study led by the University of Oxford has found that since the first coronavirus lockdown the number of people diagnosed with bowel cancer in England has fallen sharply, with a deficit persisting up to October 2020.

Being a part of cancer drug discoveries

Susan Cakebread, gives her account of being on the Tebentafusp experimental immunotherapy drug trial in 2014. A Phase 1 trial for melanoma that began here in Oxford, and is now entering Phase 3 trials after giving Susan back her life.

Investigating the effects of co-morbidities on liver cancer risk

Dr Philippa Matthews and colleagues review the associations between liver cancer risk and co-morbidities and other metabolic factors in individuals with chronic hepatitis B virus infection.

Oxfordshire-based SCAN pathway wins BMJ award

A pathway designed to investigate individuals with non-specific but concerning symptoms of cancer wins the BMJ Awards 2020 Cancer Care Team of the Year

Understanding breast cancer management in women of different ethnicities

Dr Toral Gathani investigates the associations between ethnicity and the surgical management of breast cancer, to help understand any observed differences in patterns of treatment in women of different ethnic groups

How chemotherapy impacts the body

A new study has investigated how chemotherapy impacts oesophageal cancer patients and if this determines a patient’s risk of post-operative complications

Power of the patient voice

New research from Prof Sarah Blagden demonstrates the importance of patient wellbeing in treatment decisions